Clinical Trials Browser

Recruiting × Small Cell Lung Carcinoma × tislelizumab × Clear all

NCT06838208 2025-09-24

Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC

Phase 2 Recruiting

Small Cell Lung Carcinoma

NCT06536868 2024-08-05

Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC

Phase 2 Recruiting

Small Cell Lung Carcinoma